These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23154477)
1. Serendipitous observation of hepatic metastases on (18)F-fluoride PET in a patient with infiltrating ductal carcinoma of breast: correlation with contrast enhanced CT. Basu S; Kembhavi S Clin Nucl Med; 2012 Dec; 37(12):1176-8. PubMed ID: 23154477 [TBL] [Abstract][Full Text] [Related]
2. F-18 fluoride uptake in primary breast cancer. Sarikaya I; Sharma P; Sarikaya A Ann Nucl Med; 2018 Dec; 32(10):678-686. PubMed ID: 30178199 [TBL] [Abstract][Full Text] [Related]
3. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma. Chakraborty D; Bhattacharya A; Mete UK; Mittal BR Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596 [TBL] [Abstract][Full Text] [Related]
4. Visualization of Lymph Nodal and Hepatic Metastases of Medullary Thyroid Carcinoma on 18F-Fluoride PET/CT. do Vale RH; Marin JF; Duarte PS; Sapienza MT; Buchpiguel CA Clin Nucl Med; 2015 Nov; 40(11):895-6. PubMed ID: 26444649 [TBL] [Abstract][Full Text] [Related]
5. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study. Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438 [TBL] [Abstract][Full Text] [Related]
6. [Fluoride-positron emission tomography/computed tomography for differential diagnosis in suspected bone metastasis]. Petersen H; Ogren M; Høilund-Carlsen PF Ugeskr Laeger; 2010 May; 172(20):1538-9. PubMed ID: 20483103 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients. Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259 [TBL] [Abstract][Full Text] [Related]
8. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647 [TBL] [Abstract][Full Text] [Related]
12. Abnormal F-18 fluoride uptake in intracranial meningiomas on PET/CT. Derlin T; Mester J; Klutmann S Clin Nucl Med; 2010 Oct; 35(10):806-7. PubMed ID: 20838293 [TBL] [Abstract][Full Text] [Related]
13. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging. Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015 [TBL] [Abstract][Full Text] [Related]
14. Validation of the Semiautomatic Quantification of Brito AE; Mourato F; Santos A; Mosci C; Ramos C; Etchebehere E J Nucl Med Technol; 2018 Dec; 46(4):378-383. PubMed ID: 30076246 [TBL] [Abstract][Full Text] [Related]
15. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice. Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography. Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080 [TBL] [Abstract][Full Text] [Related]
17. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid. Leboeuf R; Bénard F; Langlois MF Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803 [TBL] [Abstract][Full Text] [Related]
18. PET/CT study performed after an oral administration of 18F-fluoride. Zacchi SR; Valadares AA; Duarte PS; Sapienza MT; Buchpiguel CA Clin Nucl Med; 2013 Dec; 38(12):1012-4. PubMed ID: 24152650 [TBL] [Abstract][Full Text] [Related]
19. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer. Krakora GA; Coakley FV; Williams G; Yeh BM; Breiman RS; Qayyum A Radiology; 2004 Dec; 233(3):667-73. PubMed ID: 15516602 [TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases. Doot RK; Muzi M; Peterson LM; Schubert EK; Gralow JR; Specht JM; Mankoff DA J Nucl Med; 2010 Apr; 51(4):521-7. PubMed ID: 20237040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]